mifepristone has been researched along with Abortion, Tubal in 121 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (2.48) | 18.7374 |
| 1990's | 12 (9.92) | 18.2507 |
| 2000's | 17 (14.05) | 29.6817 |
| 2010's | 26 (21.49) | 24.3611 |
| 2020's | 63 (52.07) | 2.80 |
| Authors | Studies |
|---|---|
| Kallfa, E; Lauszus, FF; Ravn, P | 1 |
| Enzelsberger, SH; Hermann, P; Oppelt, P; Shebl, O; Trautner, PS; Wagner, H; Wetzlmair, D | 1 |
| Ahmed, A; Beeson, L; Bender-Atik, R; Bhatia, K; Bottomley, C; Brewin, J; Cheed, V; Cheong, Y; Choudhary, M; Chu, J; Coomarasamy, A; Deb, S; Devall, A; Gallos, I; Gupta, P; Hamilton, J; Hardy, P; Hassan, I; Hinshaw, K; Hodge, F; Horne, A; Izzat, F; Jeve, Y; Jones, L; Kumar, C; Naftalin, J; Nunes, N; Ogwulu, CO; Oliver, A; Papadopoulos, JF; Pringle, S; Quenby, S; Roberts, T; Ross, J; Shahid, A; Small, R; Sun, Y; Underwood, M; Watkins, L; Williams, E | 1 |
| Biggs, MA; Ehrenreich, K; Grossman, D | 1 |
| Barar, R; Biggs, MA; Blanchard, K; Ehrenreich, K; Grossman, D; Kapp, N; Moayedi, G; Morris, N; Perritt, J; Ralph, LJ; Raymond, EG; White, K | 1 |
| Bergen, S; Chavkin, W; Dragoman, M; Fofie, C | 1 |
| Gilbert, L; Poehailos, K | 1 |
| Foster, AM; LaRoche, KJ; Persaud, M; Wylie, A | 1 |
| Barar, R; Biggs, MA; Blanchard, K; Ehrenreich, K; Grossman, D; Kapp, N; Morris, N; Perritt, J; Ralph, L; White, K | 1 |
| Diao, WY; Du, L; Du, YH; Gemzell-Danielsson, K; Ho, PC; Li, RHW; Zhang, L | 1 |
| Carvajal, D; Dehlendorf, C; Fields, AB; Logan, R; Maldonado, L; McNeil, S; Perez, C; Razon, N; Wulf, S | 1 |
| Lohr, PA; Shochet, T; Whitehouse, KC | 1 |
| Boraas, CM; Coplon, L; Gold, M; Kaneshiro, B; Koenig, LR; Raymond, EG; Upadhyay, UD; Winikoff, B | 1 |
| Braat, DDM; Coppus, SFPJ; Hamel, CC; Snijders, MPLM; Vandenbussche, FPHA; Vart, P | 1 |
| Carson, A; Dunn, S; Ennis, M; Guilbert, E; Kean, L; Martin-Misener, R; Norman, WV; Pymar, H; Renner, R | 1 |
| Jiang, W; Pei, Y; Qian, Y; Zheng, C | 1 |
| Cameron, S; Morroni, C; Reynolds-Wright, JJ; Woldetsadik, MA | 1 |
| Cottrill, A; Dethier, D; Fortin, J; Fulcher, IR; Gilbert, A; Goldberg, AB; Hofer, RK; Janiak, E; Roncari, D | 1 |
| Abernathy, A; Flynn, AN; Koelper, NC; McAllister, A; Roe, AH; Sammel, MD; Schreiber, CA; Sonalkar, S | 1 |
| Fitzgerald, K; Laursen, L; Whitaker, AK; Young, D | 1 |
| Gutman, SM; Harvie, HS; Koelper, NC; Loza-Avalos, SE; Nagendra, D; Schreiber, CA; Sonalkar, S | 1 |
| Cao, C; Chen, M; Hu, Z; Shu, C; Yang, X; Zhou, Q | 1 |
| Constant, D; Endler, M; Gemzell Danielsson, K; Gomperts, R; Grossman, D; Petro, G; Weinryb, M | 1 |
| Shaker, M; Smith, A | 1 |
| An, J; Chen, R; Lu, Y; Su, R; Wang, W | 1 |
| Cameron, S; Reynolds-Wright, JJ; Tai, NQR | 1 |
| Speer, L | 1 |
| Gong, Y; Hu, YF; Huang, GY; Li, W; Sheng, F; Wu, MY; Yang, Y; Zhang, LL; Zhang, P; Zou, L | 1 |
| Liu, N; Ray, JG | 1 |
| Boerma, C; Brandell, K; Cameron, S; Gemzell-Danielsson, K; Gibson, G; Heikinheimo, O; Hognert, H; Reynolds-Wright, JJ; Tuladhar, H | 1 |
| Fortin, J; Gelfand, D; Gilbert, AL; Goldberg, AB; Roncari, D | 1 |
| Ganatra, B; Grossman, A; Lavelanet, A; Prata, N; Rehnström Loi, U; Williams, N | 1 |
| Dunn, S; Guilbert, ER; Munro, SB; Norman, WV | 1 |
| Flink-Bochacki, R; Phillips, AM; Rachad, S | 1 |
| Du, H; Hao, Y; Jiang, M; Li, D; Liang, X; Lv, J; Ma, Y; Song, Y; Wang, S; Zhang, L | 1 |
| Boyd, K; Grant, M; Koenig, LR; Raymond, EG; Shochet, T; Upadhyay, U; Weaver, MA | 1 |
| Fortin, J; Goldberg, AB; Hoe, E; Janiak, E; Neill, S | 1 |
| Fortin, J; Goldberg, A; Janiak, E; Mokashi, M; Neill, S | 1 |
| Boos, EW; Dusetzina, SB; Horta, M; Leech, AA; Thompson, I | 1 |
| Baker, CC; Creinin, MD; Flynn, AN; Han, G; Wu, BT | 1 |
| Tanne, JH | 1 |
| Bettencourt-Silva, B; Brás, F; Cunha, AI; Furtado, JM; Lopes-Guerra, C; Miguelote, R; Miranda, C; Rego, MT; Sousa-Santos, R | 1 |
| Bercu, C; Egwuatu, I; Gerdts, C; Grosso, B; Jayaweera, R; Kristianingrum, IA; Moseson, H; Nmezi, S; Zurbriggen, R | 1 |
| Barinov, SV; Kadcyna, TV; Lazareva, OV; Medyannikova, IV; Shamina, IV; Shkabarnya, LL; Tirskaya, YI | 1 |
| Bergeson, K; Kline, RJ; Prasad, S | 1 |
| Grossman, D; Harris, LH | 1 |
| Foster, AM; LaRoche, KJ | 1 |
| Atrio, JM; Creinin, MD; Koelper, N; McAllister, A; Sammel, MD; Schreiber, CA; Sonalkar, S | 1 |
| Doctoroff, J; Foster, AM; Mark, A; Yalahow, A | 1 |
| Bullard, KA; Cisternas, C; Gerdts, C; Grosso, B; Moseson, H; Vera, V | 1 |
| Beaman, J; Prifti, C; Schwarz, EB; Sobota, M | 1 |
| Parsons, JA | 1 |
| Barnhart, K | 1 |
| Egwuatu, I; Filippa, S; Gerdts, C; Grosso, B; Jayaweera, R; Keefe-Oates, B; Kristianingrum, I; Moseson, H; Motana, R; Nmezi, S; Raifman, S; Zurbriggen, R | 1 |
| Flynn, AN; Koelper, N; McAllister, A; Roe, AH; Sammel, MD; Schreiber, CA | 1 |
| Anger, HA; Baldwin, MK; Banks, J; Bednarek, P; Boraas, C; Chong, E; Coplon, L; Grant, M; Haskell, S; Kaneshiro, B; Platais, I; Raymond, EG; Shochet, T; Tocce, K | 1 |
| Glaser, K; Whitehair, J | 1 |
| Early, J; Macnaughton, H; Nothnagle, M | 1 |
| Calloway, D; Janiak, E; Stulberg, DB | 1 |
| Brubaker, L; Prine, L; Riker, L; Rubin, SE; Srinivasulu, S; Yavari, R | 1 |
| Flynn, AN; Jiang, E; Koelper, N; Martin, B; McAllister, A; Roe, AH; Schreiber, CA | 1 |
| Biggs, MA; Grossman, D; Raifman, S; Ralph, L | 1 |
| Beeson, LE; Coomarasamy, A; Devall, AJ; Do, V; Gallos, ID; Ghosh, J; Gülmezoglu, AM; Jeffery, HC; Lavelanet, A; Papadopoulou, A; Price, MJ; Tobias, A; Tunçalp, Ö | 1 |
| Anger, HA; Banks, J; Boraas, C; Coplon, L; Grant, M; Haskell, S; Platais, I; Raymond, EG; Shochet, T; Tocce, K; Winikoff, B | 1 |
| Chaturachinda, K | 1 |
| Haverinen, A; Heikinheimo, O; Jahangiri, R; Männistö, J; Mentula, M; Niinimäki, M | 1 |
| Aiken, ARA | 1 |
| Dunford, A; Fyfe, R | 1 |
| Atrio, J; Barnhart, KT; Creinin, MD; Ratcliffe, SJ; Schreiber, CA; Sonalkar, S | 1 |
| Davis, AR; Westhoff, CL | 1 |
| Blanchard, K; Constant, D; Grossman, D; Harries, J; Kluge, J; Lince-Deroche, N; Sinanovic, E | 1 |
| Du, M; Gu, Y; Huang, J; Jin, M; Wan, B; Xue, M; Ye, W; Yu, H; Zhang, J; Zhang, Y | 1 |
| H Al Wattar, B; Khan, KS; Murugesu, N; Tobias, A; Zamora, J | 1 |
| Coppus, SF; Hamel, CC; Snijders, MP; van den Berg, J; Vandenbussche, FP | 1 |
| Colleselli, V; D'Costa, E; Mangesius, S; Schreiber, CA; Seeber, BE; Wildt, L | 1 |
| Bouschbacher, L; Collin, P; de Malartic, CM; Maatouk, A; Morel, O; Welter, E | 1 |
| Coppus, SF; de Heus, R; Snijders, MP; van den Bent, JM; van den Berg, J; Vandenbussche, FP | 1 |
| Acharya, R; Filippi, V; Powell-Jackson, T; Ronsmans, C | 1 |
| Almeida, H; Gaio, AR; Guedes-Martins, L; Macedo, F; Reynolds, A; Saraiva, JP | 1 |
| Coppus, SFPJ; Gordon, BBM; Snijders, MPML; van den Berg, J; Vandenbussche, FPHA | 1 |
| Dyer, C | 1 |
| Arnott, G; El-Haddad, J; Foster, AM; Sheinfeld, L | 1 |
| Bartosik, T; Brunner, C; Ciresa-Koenig, A; Colleselli, V; Marth, C; Nell, T; Seeber, B; Wildt, L | 1 |
| Chen, BA; Creinin, MD | 1 |
| Hartikainen, AL; Karinen, P; Niinimäki, M; Pouta, A | 1 |
| Creinin, MD; Kollitz, KM; Lohr, PA; Meyn, LA | 1 |
| Bussieres, L; Camus, E; Fauconnier, A; Huchon, C; Machevin, E; Torre, A | 1 |
| He, B; Lv, F; Wang, J; Wang, L; Wang, N; Xu, X; Zhang, S | 1 |
| Amar, E; Barjhoux, CE; Bernard, N; Bos-Thompson, MA; Carlier, P; Descotes, J; Elefant, E; Tebacher, M; Vial, T | 1 |
| Chen, G; Fu, G; Liu, Y; Zhang, Y | 1 |
| Baton Saint-mleux, C; Bourget, P; Fernandez, H; Frydman, R; Lelaidier, C | 1 |
| Body, G; de Poncheville, L; Lansac, J; Marret, H; Perrotin, F | 1 |
| Coughlin, LB; Haddad, NG; Long, A; Roberts, D | 1 |
| Bugg, G; Greenland, H; Ogunbiyi, I; Tasker, M | 1 |
| Chen, A; Cheng, Y; Gao, E; Luo, L; Meirik, O; Wang, X; Wu, SZ; Yuan, W; Zhou, L | 1 |
| Grimes, DA | 1 |
| Chekhranova, MK; Iatsyshina, SB; Karpova, SK; Morozova, MS; Pankov, IuA; Sazina, ET; Zaĭtseva, TS | 1 |
| Kotsuji, F; Nishijima, K; Shukunami, K | 1 |
| Couzin, J | 1 |
| Jouppila, P; Martikainen, H; Niinimäki, M; Talvensaari-Mattila, A | 1 |
| Ho, PC; Tang, OS | 2 |
| Arbel, R; Brzezinski, A; Haimov-Kochman, R; Laufer, N; Sciaky-Tamir, Y; Yagel, S | 1 |
| Chen, TH; Kuo, TC; Li, YT | 1 |
| Asribekova, MK; Astakhova, TM; Goncharova, VN; Karpova, SK; Morozova, MS; Murashko, LE; Zaĭtseva, TS | 1 |
| Bygdeman, M | 1 |
| van Gend, D | 1 |
| Elstein, M; Macrow, P | 1 |
| Dombay, Gy; Par, G; Smart, YC; Szekeres-Bartho, J; Volgyi, Z | 1 |
| Jurkovic, D | 1 |
| Hahlin, M; Nielsen, S; Platz-Christensen, J | 1 |
| Kovács, L; Zalányi, S | 1 |
| Bachelot, A; Cludy, L; Spira, A | 1 |
| Börner, A; Carol, W; Klinger, G; Michels, W; Romero, KR | 1 |
| Aldhous, P; Coles, P | 1 |
| Chaouat, G; Kinsky, R; Szekeres-Bartho, J; Varga, P | 1 |
| Fujimoto, S; Kobamatsu, Y; Makinoda, S; Mikuni, M; Nakajin, K; Negishi, H; Okuda, T; Sogame, M; Tabata, M | 1 |
| Jost, A | 1 |
| Baulieu, E | 1 |
18 review(s) available for mifepristone and Abortion, Tubal
| Article | Year |
|---|---|
[Control of the level of human chorionic gonadotropin in urine compared to the level of serum after medically provoked abortion is a safe alternative].
Topics: Abortion, Induced; Abortion, Spontaneous; Chorionic Gonadotropin; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2021 |
Pain management for medical abortion before 14 weeks' gestation.
Topics: Abortion, Induced; Abortion, Spontaneous; Acetaminophen; Female; Humans; Ibuprofen; Mifepristone; Misoprostol; Pain; Pain Management; Pregabalin; Pregnancy | 2022 |
Comparison of vaginal and buccal misoprostol after mifepristone for medication abortion through 70 days of gestation: A retrospective chart review.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Administration, Intravaginal; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies; Retrospective Studies | 2022 |
First Trimester Miscarriage.
Topics: Abortion, Spontaneous; Cost-Benefit Analysis; Female; Gestational Age; Humans; Mifepristone; Pregnancy; Pregnancy Trimester, First | 2022 |
Medical Abortion before Confirmed Intrauterine Pregnancy: A Systematic Review.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy, Ectopic | 2022 |
Early pregnancy loss medical management in clinical practice.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Cicatrix; Female; Humans; Mifepristone; Misoprostol; Multicenter Studies as Topic; Pregnancy; Pregnancy, Ectopic; Retrospective Studies | 2023 |
Complications of Unsafe and Self-Managed Abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; Adult; Diagnosis, Differential; Female; Health Policy; Humans; Mifepristone; Misoprostol; Pregnancy; Self-Management; United States | 2020 |
Trends in medication abortion provision before and after the introduction of mifepristone: A study of the National Abortion Federation's Canadian member services.
Topics: Abortion, Induced; Abortion, Spontaneous; Canada; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2020 |
Medication to Manage Abortion and Miscarriage.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Gestational Age; Humans; Middle Aged; Mifepristone; Misoprostol; Pregnancy | 2020 |
Methods for managing miscarriage: a network meta-analysis.
Topics: Abortion, Incomplete; Abortion, Missed; Abortion, Spontaneous; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Network Meta-Analysis; Oxytocics; Placebos; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topic; Suction; Vacuum Curettage; Watchful Waiting | 2021 |
Management of first-trimester miscarriage: a systematic review and network meta-analysis.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Network Meta-Analysis; Pregnancy; Pregnancy Trimester, First; Vacuum Curettage | 2019 |
The added value of mifepristone to non-surgical treatment regimens for uterine evacuation in case of early pregnancy failure: a systematic review of the literature.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Clinical Protocols; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2015 |
Medical management of early pregnancy failure: efficacy.
Topics: Abortifacient Agents; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Randomized Controlled Trials as Topic; Treatment Outcome | 2008 |
[Spontaneous abortions of first trimester pregnancy: is uterine aspiration still in line?].
Topics: Abortifacient Agents; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prostaglandins; Vacuum Extraction, Obstetrical | 2002 |
The use of misoprostol for early pregnancy failure.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Ultrasonography, Prenatal | 2006 |
Clinical applications of mifepristone.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Contraceptive Agents; Female; Genital Diseases, Female; Humans; Mifepristone; Pregnancy | 2006 |
Modern management of miscarriage: is there a place for non-surgical treatment?
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Missed; Abortion, Spontaneous; Dilatation and Curettage; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 1998 |
[Effect of antigestagens on human reproduction].
Topics: Abortifacient Agents, Steroidal; Abortion, Spontaneous; Abortion, Therapeutic; Contraceptives, Oral, Hormonal; Endometrial Neoplasms; Endometriosis; Female; Hormone Antagonists; Humans; Labor, Induced; Mifepristone; Pregnancy; Progesterone | 2001 |
19 trial(s) available for mifepristone and Abortion, Tubal
| Article | Year |
|---|---|
Mifepristone and misoprostol versus placebo and misoprostol for resolution of miscarriage in women diagnosed with missed miscarriage: the MifeMiso RCT.
Topics: Abortion, Spontaneous; Cost-Benefit Analysis; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Technology Assessment, Biomedical | 2021 |
Prospective open-label non-inferiority randomised controlled trial comparing letrozole and mifepristone pretreatment in medical management of first trimester missed miscarriage: study protocol.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Letrozole; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome | 2022 |
Predicting the likelihood of successful medical treatment of early pregnancy loss: development and internal validation of a clinical prediction model.
Topics: Abortion, Spontaneous; Colic; Female; Humans; Male; Mifepristone; Models, Statistical; Pregnancy; Probability; Prognosis; Uterine Hemorrhage | 2022 |
Medical management of early pregnancy loss is cost-effective compared with office uterine aspiration.
Topics: Abortion, Spontaneous; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2022 |
A telemedicine model for abortion in South Africa: a randomised, controlled, non-inferiority trial.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; South Africa; Telemedicine | 2022 |
The role of mifepristone on first trimester miscarriage treatment - A double-blind randomized controlled trial - MiFirsT.
Topics: Abortion, Missed; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2023 |
The use of an osmotic dilator for induction of miscarriage in patients with the second trimester missed miscarriage.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second | 2021 |
Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Adult; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Parity; Pregnancy; Treatment Outcome; Uterine Hemorrhage | 2020 |
Timing and efficacy of mifepristone pretreatment for medical management of early pregnancy loss.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome | 2021 |
The effect of mifepristone pretreatment on bleeding and pain during medical management of early pregnancy loss.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pain; Pregnancy | 2021 |
Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Administration, Intravaginal; Administration, Oral; Adult; Drug Therapy, Combination; Embryo, Mammalian; Female; Fetal Death; Gestational Sac; Hemorrhage; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Ultrasonography | 2018 |
[Association of mifepristone and misoprostol for the medical management of early pregnancy failure].
Topics: Abortion, Spontaneous; Adult; Drug Therapy, Combination; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Oxytocics; Pregnancy; Pregnancy Trimester, First; Retrospective Studies; Treatment Outcome | 2014 |
Treating miscarriages: a randomised study of cost-effectiveness in medical or surgical choice.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Spontaneous; Adolescent; Adult; Cost-Benefit Analysis; Female; Hospital Costs; Humans; Mifepristone; Misoprostol; Patient Satisfaction; Pregnancy; Prospective Studies; Young Adult | 2009 |
Immediate versus delayed medical treatment for first-trimester miscarriage: a randomized trial.
Topics: Abortifacient Agents; Abortion, Spontaneous; Adult; Female; Hemorrhage; Humans; Infections; Mifepristone; Misoprostol; Pain; Pregnancy; Pregnancy Trimester, First; Treatment Outcome; Vacuum Curettage | 2012 |
A randomized study comparing efficacy and patient satisfaction in medical or surgical treatment of miscarriage.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Adult; Female; Humans; Incidence; Infections; Mifepristone; Misoprostol; Pain; Patient Satisfaction; Pregnancy; Pregnancy Trimester, First; Treatment Outcome; Vacuum Curettage | 2006 |
Efficacy of simultaneous use of mifepristone and misoprostol for early abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Adolescent; Adult; Drug Administration Schedule; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Oxytocics; Parity; Pregnancy | 2008 |
Randomised trial comparing expectant with medical management for first trimester miscarriages.
Topics: Abortifacient Agents, Steroidal; Abortion, Spontaneous; Adult; Ambulatory Care; Chorionic Gonadotropin; Female; Humans; Length of Stay; Mifepristone; Pain; Placenta, Retained; Pregnancy; Pregnancy Trimester, First; Progesterone | 1999 |
Conditions for choosing between drug-induced and surgical abortions.
Topics: Abortion, Induced; Abortion, Spontaneous; Adolescent; Adult; Anesthesia, General; Anesthesia, Local; Choice Behavior; Female; France; Humans; Mifepristone; Pregnancy; Prospective Studies; Regression Analysis; Socioeconomic Factors; Surveys and Questionnaires; Vacuum Curettage | 1992 |
Hormone analytical and carrier protein alternations following administration of mifepristone (RU 486) for termination of early pregnancy.
Topics: Abortion, Spontaneous; Adult; Carrier Proteins; Chorionic Gonadotropin; Estradiol; Female; Hormones; Humans; Hydrocortisone; Mifepristone; Pregnancy; Pregnancy Trimester, First; Progesterone; Sex Hormone-Binding Globulin | 1991 |
84 other study(ies) available for mifepristone and Abortion, Tubal
| Article | Year |
|---|---|
Bleeding pattern after medical management of early pregnancy loss with mifepristone-misoprostol and its prognostic value: a prospective observational cohort study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prognosis; Prospective Studies; Uterine Hemorrhage | 2022 |
Making the case for advance provision of mifepristone and misoprostol for abortion in the United States.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; United States | 2022 |
Accuracy of self-assessment of gestational duration among people seeking abortion.
Topics: Abortion, Induced; Abortion, Spontaneous; COVID-19; Female; Gestational Age; Humans; Mifepristone; Misoprostol; Pregnancy; Self-Assessment | 2022 |
Integrating self-managed medication abortion with medical care.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Self-Management | 2022 |
Risks of and Indications for Mifepristone for Medication Abortion.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Pregnancy | 2022 |
Integrating mifepristone into primary care in Canada's capital: A multi-methods exploration of the Medical Abortion Access Project.
Topics: Abortion, Induced; Abortion, Spontaneous; Canada; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Primary Health Care | 2022 |
A cross-sectional survey of U.S. abortion patients' interest in obtaining medication abortion over the counter.
Topics: Abortion, Induced; Abortion, Spontaneous; Adolescent; Appointments and Schedules; Cross-Sectional Studies; Female; Humans; Mifepristone; Pregnancy; Surveys and Questionnaires; United States | 2022 |
Exploring the impact of mifepristone's risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics✰,✰✰.
Topics: Abortion, Induced; Abortion, Spontaneous; Family Practice; Female; Humans; Mifepristone; Pregnancy; Primary Health Care; Risk Evaluation and Mitigation; United States | 2022 |
Efficacy of a low-sensitivity urine pregnancy test for identifying ongoing pregnancy after medication abortion at 64 to 70 days of gestation.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Tests | 2022 |
Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study.
Topics: Abortion, Induced; Abortion, Spontaneous; Cohort Studies; COVID-19; Female; Humans; Mifepristone; Pandemics; Pregnancy; Pregnancy, Ectopic; Retrospective Studies | 2022 |
Provision of first-trimester medication abortion in 2019: Results from the Canadian abortion provider survey.
Topics: Abortion, Induced; Abortion, Spontaneous; Canada; Cross-Sectional Studies; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2022 |
Astilbin improves pregnancy outcome in rats with recurrent spontaneous abortion by regulating Th1/Th2 balance.
Topics: Abortion, Spontaneous; Animals; Female; Flavonols; Humans; Hydroxyurea; Interleukin-10; Interleukin-2; Interleukin-4; Mifepristone; Placenta; Prednisone; Pregnancy; Pregnancy Outcome; Rats; Rats, Sprague-Dawley; T-Box Domain Proteins; Th1 Cells; Th2 Cells | 2022 |
Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; Chorionic Gonadotropin; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy, Ectopic; Retrospective Studies | 2022 |
Utility and Limitations of Human Chorionic Gonadotropin Levels for Remote Follow-up After Medical Management of Early Pregnancy Loss.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; Chorionic Gonadotropin; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Pregnancy | 2022 |
A retrospective study of estrogen in the pretreatment for medical management of early pregnancy loss and the inference from intrauterine adhesion.
Topics: Abortion, Spontaneous; Carboprost; Estradiol; Estrogens; Female; Humans; Mifepristone; Pregnancy; Retrospective Studies; Suppositories | 2022 |
Predictor assessment of complete miscarriage after medical treatment for early pregnancy loss in women with previous cesarean section.
Topics: Abortion, Spontaneous; Cesarean Section; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2022 |
Very early medical abortion: treatment with mifepristone and misoprostol before ultrasonographic visualisation of an intrauterine pregnancy.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy, Ectopic; Retrospective Studies | 2023 |
Medication Abortion a Reasonable Option for Pregnancy of Unknown Location.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Pregnancy | 2022 |
Integrative transcriptomics and proteomics analyses to reveal the therapeutic effect and mechanism of Buxue Yimu Pills in medical-induced incomplete abortion rats.
Topics: Abortion, Incomplete; Abortion, Induced; Abortion, Spontaneous; Animals; Dinoprost; Female; Matrix Metalloproteinase 7; Mifepristone; Misoprostol; Pregnancy; Proteomics; Rats; Transcriptome | 2023 |
Short-Term Adverse Outcomes After Mifepristone-Misoprostol Versus Procedural Induced Abortion : A Population-Based Propensity-Weighted Study.
Topics: Abortion, Induced; Abortion, Spontaneous; Adult; Cohort Studies; Female; Humans; Mifepristone; Misoprostol; Ontario; Pregnancy; Pregnancy Trimester, First | 2023 |
At-home urine pregnancy test assessment after mifepristone and misoprostol for undesired pregnancy of unknown location.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Tests | 2023 |
In-country availability of medical abortion medicines: a description of the framework and methodology of the WHO landscape assessments.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; World Health Organization | 2023 |
Advancing Reproductive Health through Policy-Engaged Research in Abortion Care.
Topics: Abortion, Spontaneous; Canada; Female; Health Policy; Humans; Mifepristone; Misoprostol; Pregnancy; Reproductive Health; United States | 2022 |
The association between abortion restrictions and patient-centered care for early pregnancy loss at US obstetrics-gynecology residency programs.
Topics: Abortion, Induced; Abortion, Spontaneous; Cross-Sectional Studies; Female; Gynecology; Humans; Internship and Residency; Mifepristone; Obstetrics; Patient-Centered Care; Pregnancy | 2023 |
Shoutai Wan regulates glycolysis imbalance at the maternal-fetal interface in threatened abortion mice.
Topics: Abortion, Induced; Abortion, Spontaneous; Abortion, Threatened; Animals; Female; Humans; Hydrocortisone; Mice; Mifepristone; Pregnancy | 2023 |
Clinical outcomes of medication abortion using misoprostol-only: A retrospective chart review at an abortion provider organization in the United States.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; COVID-19; Female; Humans; Mifepristone; Misoprostol; Pandemics; Pregnancy; Retrospective Studies; United States | 2023 |
Management of early pregnancy loss among obstetrician-gynecologists in Massachusetts and barriers to mifepristone use.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Gynecologists; Humans; Massachusetts; Mifepristone; Misoprostol; Obstetricians; Pregnancy | 2023 |
Mifepristone use for early pregnancy loss: A qualitative study of barriers and facilitators among OB/GYNS in Massachusetts, USA.
Topics: Abortion, Induced; Abortion, Spontaneous; COVID-19; Female; Humans; Massachusetts; Mifepristone; Pandemics; Pregnancy; United States | 2023 |
Trends in the Use of Mifepristone for Medical Management of Early Pregnancy Loss From 2016 to 2020.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2023 |
US federal court upholds limits on abortion drug mifepristone.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Pregnancy | 2023 |
Medication Abortion Safety and Effectiveness With Misoprostol Alone.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prospective Studies | 2023 |
PURL: Early pregnancy loss: Pretreat with mifepristone?
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Administration, Oral; Adult; Drug Therapy, Combination; Family Practice; Female; Humans; Mifepristone; Misoprostol; Practice Guidelines as Topic; Pregnancy | 2019 |
"It gives you autonomy over your own choices": A qualitative study of Canadian abortion patients' experiences with mifepristone and misoprostol.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Canada; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2020 |
Effectiveness of self-managed medication abortion between 13 and 24 weeks gestation: A retrospective review of case records from accompaniment groups in Argentina, Chile, and Ecuador.
Topics: Abortion, Induced; Abortion, Spontaneous; Argentina; Chile; Ecuador; Female; Humans; Mifepristone; Misoprostol; Placenta; Pregnancy; Retrospective Studies | 2020 |
2017-19 governmental decisions to allow home use of misoprostol for early medical abortion in the UK.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; United Kingdom | 2020 |
Medical management of miscarriage with mifepristone.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Double-Blind Method; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 2020 |
Self-managed medication abortion outcomes: results from a prospective pilot study.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pilot Projects; Pregnancy; Prospective Studies; Self Administration; Self-Management; Treatment Outcome | 2020 |
"False positive" urine pregnancy test results after successful medication abortion.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Tests | 2021 |
Missing mifepristone at tribal health facilities serving native Americans.
Topics: Abortion, Induced; Abortion, Spontaneous; American Indian or Alaska Native; Female; Health Facilities; Humans; Mifepristone; Misoprostol; Pregnancy | 2021 |
Mifepristone and Misoprostol for Early Pregnancy Loss and Medication Abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Prenatal Care | 2021 |
Mifepristone restrictions and primary care: Breaking the cycle of stigma through a learning collaborative model in the United States.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Pregnancy; Primary Health Care; Social Stigma; United States | 2021 |
US clinicians' perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Health Services Accessibility; Humans; Mifepristone; Pregnancy; Primary Health Care; United States | 2021 |
"I'll just deal with this on my own": a qualitative exploration of experiences with self-managed abortion in the United States.
Topics: Abortion, Induced; Abortion, Spontaneous; Adult; Female; Health Services Accessibility; Humans; Interviews as Topic; Mifepristone; Misoprostol; Motivation; Pregnancy; Qualitative Research; Self-Management; United States | 2021 |
Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.S.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Postal Service; Pregnancy; Telemedicine; Ultrasonography | 2021 |
Over-the-counter medical termination of pregnancy: to be or not to be?
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Pregnancy | 2017 |
Medical treatment of second-trimester fetal miscarriage; A retrospective analysis.
Topics: Abortion, Spontaneous; Adult; Drug Administration Schedule; Female; Humans; Length of Stay; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies | 2017 |
Self-sourced online and self-directed at home: a new frontier for abortion in the United States.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Internet; Mifepristone; Misoprostol; Pregnancy; United States | 2018 |
Combination therapy with mifepristone and misoprostol for the management of first trimester miscarriage: Improved success.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Spontaneous; Adult; Cohort Studies; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Retrospective Studies; Treatment Outcome | 2018 |
Abortion-Related Adverse Events by Facility Type: Reassurance From a National Analysis.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Humans; Mifepristone; Pregnancy | 2018 |
The costs and cost effectiveness of providing second-trimester medical and surgical safe abortion services in Western Cape Province, South Africa.
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Spontaneous; Adult; Cost-Benefit Analysis; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; South Africa | 2018 |
ACOG Practice Bulletin No. 200: Early Pregnancy Loss.
Topics: Abortifacient Agents; Abortion, Spontaneous; Dilatation and Curettage; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Rh Isoimmunization; Rho(D) Immune Globulin; Ultrasonography; Watchful Waiting | 2018 |
Protective role of GPR120 in the maintenance of pregnancy by promoting decidualization via regulation of glucose metabolism.
Topics: Abortion, Spontaneous; Adult; Animals; Cell Line; Decidua; Disease Models, Animal; Down-Regulation; Fatty Acids, Omega-3; Female; Glucose; Humans; Lipopolysaccharides; Mice; Mifepristone; Pentose Phosphate Pathway; Pregnancy; Receptors, G-Protein-Coupled; Stromal Cells | 2019 |
ACOG Practice Bulletin No. 200 Summary: Early Pregnancy Loss.
Topics: Abortifacient Agents; Abortion, Spontaneous; Dilatation and Curettage; Female; Humans; Mifepristone; Misoprostol; Practice Guidelines as Topic; Pregnancy; Pregnancy Trimester, First; Rh Isoimmunization; Rho(D) Immune Globulin; Ultrasonography; Watchful Waiting | 2018 |
Current and future expectations of mifepristone treatment in early pregnancy failure: a survey among Dutch gynaecologists.
Topics: Abortifacient Agents; Abortion, Spontaneous; Female; Gynecology; Humans; Mifepristone; Misoprostol; Netherlands; Pregnancy; Surveys and Questionnaires | 2019 |
Medical management of early pregnancy failure (EPF): a retrospective analysis of a combined protocol of mifepristone and misoprostol used in clinical practice.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Spontaneous; Adolescent; Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Logistic Models; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies; Young Adult | 2014 |
Sequential use of mifepristone and misoprostol in treatment of early pregnancy failure appears more effective than misoprostol alone: a retrospective study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Administration, Intravaginal; Administration, Oral; Adult; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Retrospective Studies; Treatment Outcome | 2014 |
Delivering medical abortion at scale: a study of the retail market for medical abortion in Madhya Pradesh, India.
Topics: Abortion, Induced; Abortion, Spontaneous; Adult; Female; Humans; India; Male; Mifepristone; Misoprostol; Pharmacists; Pregnancy; Private Sector | 2015 |
Uterine artery Doppler in the management of early pregnancy loss: a prospective, longitudinal study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Spontaneous; Adult; Cohort Studies; Dilatation and Curettage; Disease Management; Female; Humans; Longitudinal Studies; Middle Aged; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prognosis; Prospective Studies; Pulsatile Flow; Ultrasonography, Doppler; Uterine Artery; Vascular Resistance; Young Adult | 2015 |
Woman in Northern Ireland who bought abortion pills online is given suspended sentence.
Topics: Abortifacient Agents; Abortion, Criminal; Abortion, Spontaneous; Female; Humans; Internet; Mifepristone; Misoprostol; Northern Ireland; Pregnancy; Punishment; Young Adult | 2016 |
Assessing abortion coverage in nurse practitioner programs in Canada: a national survey of program directors.
Topics: Abortion, Induced; Abortion, Spontaneous; Canada; Curriculum; Female; Humans; Male; Mifepristone; Misoprostol; Nurse Practitioners; Physician Executives; Pregnancy; Reproductive Health Services; Surveys and Questionnaires | 2016 |
Marked improvement in the success rate of medical management of early pregnancy failure following the implementation of a novel institutional protocol and treatment guidelines: a follow-up study.
Topics: Abortifacient Agents; Abortion, Spontaneous; Administration, Intravaginal; Adolescent; Adult; Clinical Protocols; Female; Follow-Up Studies; Humans; Middle Aged; Mifepristone; Misoprostol; Practice Guidelines as Topic; Pregnancy; Retrospective Studies | 2016 |
Mifepristone and misoprostol for early pregnancy failure: a cohort analysis.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Adolescent; Adult; Cohort Studies; Drug Administration Schedule; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Treatment Outcome | 2011 |
Repeated abortion affects subsequent pregnancy outcomes in BALB/c mice.
Topics: Abortion, Induced; Abortion, Spontaneous; Animals; Birth Weight; Female; Gene Expression Regulation; Litter Size; Male; Mice; Mice, Inbred BALB C; Mifepristone; Placenta; Pregnancy; Pregnancy Outcome; Safety; Sex Ratio; Sperm Motility; Time Factors | 2012 |
Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study.
Topics: Abortifacient Agents, Steroidal; Abortion, Spontaneous; Adult; Congenital Abnormalities; Female; Follow-Up Studies; France; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Premature Birth; Prospective Studies | 2013 |
[Apoptosis and expression of relative genes in early pregnant chorionic villi and decidua].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Apoptosis; bcl-2-Associated X Protein; Chorionic Villi; Decidua; Fas Ligand Protein; fas Receptor; Female; Humans; Membrane Glycoproteins; Mifepristone; Pregnancy; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger | 2002 |
[Inducing embryo expulsion in women with spontaneous fetal death in the first trimester. Use of mifepristone (RU-486) in a prospective, randomized, double blind study].
Topics: Abortion, Spontaneous; Biology; Demography; Developed Countries; Disease; Double-Blind Method; Endocrine System; Europe; Fetal Death; France; Hormone Antagonists; Hormones; Mifepristone; Mortality; Physiology; Population; Population Dynamics; Pregnancy Complications; Research | 1993 |
Medical management of first trimester miscarriage (blighted ovum and missed abortion): is it effective?
Topics: Abortion, Missed; Abortion, Spontaneous; Administration, Oral; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endosonography; Female; Follow-Up Studies; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Risk Assessment; Treatment Outcome | 2004 |
Medical treatment of miscarriage in a district general hospital is safe and effective up to 12 weeks' gestation.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Adult; Female; Hospitals, District; Hospitals, General; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First; Retrospective Studies; Ultrasonography; United Kingdom | 2003 |
Mifepristone-induced early abortion and outcome of subsequent wanted pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Spontaneous; Case-Control Studies; China; Female; Follow-Up Studies; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Maternal Exposure; Mifepristone; Pregnancy; Pregnancy Outcome | 2004 |
Risks of mifepristone abortion in context.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Cause of Death; Female; Humans; Mifepristone; Risk Factors; Survival Rate | 2005 |
[Molecular and genetic study of the role of hormones, receptors, and enzymes in regulation of reproduction, lipid metabolism, and other human physiological functions].
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Animals; Appetite; beta-Lipotropin; Cattle; Diabetes Mellitus, Type 1; Female; Genetic Engineering; Glutamate Decarboxylase; Humans; Leptin; Lipid Metabolism; Male; Mifepristone; Mutation; Obesity; Pregnancy; Receptors, Estrogen; Receptors, Melanocortin; Receptors, Progesterone; Reproduction; Research; RNA, Messenger; Sterol Esterase; Swine; Uterus | 2005 |
Medical vs. surgical management of early pregnancy failure.
Topics: Abortifacient Agents; Abortion, Induced; Abortion, Spontaneous; Clostridium Infections; Clostridium sordellii; Endometritis; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Shock, Septic | 2005 |
infectious disease. RU-486-linked deaths open debate about risky bacteria.
Topics: Abortifacient Agents, Steroidal; Abortion, Spontaneous; Abortion, Therapeutic; Animals; Clostridioides difficile; Clostridium Infections; Clostridium sordellii; Enterocolitis, Pseudomembranous; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Complications, Infectious | 2006 |
Risk factors for unsuccessful medical abortion with mifepristone and misoprostol.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Abortion, Spontaneous; Adolescent; Adult; Chorionic Gonadotropin, beta Subunit, Human; Drug Therapy, Combination; Female; Humans; Logistic Models; Middle Aged; Mifepristone; Misoprostol; Parity; Pregnancy; Retrospective Studies; Risk Factors; Treatment Failure; Treatment Outcome; Ultrasonography; Uterus | 2007 |
[Sex hormone receptors, prostaglandins and cAMP, in functional activity of the uterus].
Topics: Abortion, Induced; Abortion, Spontaneous; Cyclic AMP; Decidua; Dinoprost; Dinoprostone; Female; Humans; Mifepristone; Pregnancy; Receptors, Estrogen; Receptors, Progesterone | 1994 |
[Treatment in miscarriage and abortion. Widened use of drugs has many advantages].
Topics: Abortion, Missed; Abortion, Spontaneous; Drug Therapy, Combination; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Receptors, Progesterone | 1994 |
Medical management of miscarriage with RU486.
Topics: Abortion, Induced; Abortion, Spontaneous; Female; Fetal Death; Humans; Mifepristone; Pregnancy | 1993 |
Managing miscarriage medically.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Spontaneous; Dinoprostone; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 1993 |
The antiabortive effect of progesterone-induced blocking factor in mice is manifested by modulating NK activity.
Topics: Abortion, Spontaneous; Animals; Antibodies, Monoclonal; Cytotoxicity, Immunologic; Female; Fetal Resorption; Killer Cells, Natural; Male; Mice; Mice, Inbred BALB C; Mifepristone; Pregnancy; Pregnancy Proteins; Progesterone; Rabbits; Suppressor Factors, Immunologic | 1997 |
Abortion pill. French pill for Britain?
Topics: Abortion, Spontaneous; Female; France; Humans; Legislation, Drug; Mifepristone; Pregnancy; United Kingdom | 1990 |
Progesterone-mediated immunosuppression and the maintenance of pregnancy.
Topics: Abortion, Spontaneous; Animals; Biological Factors; Female; Fetal Resorption; Humans; Immune Tolerance; Immunization, Passive; Lymphocyte Transfusion; Lymphocytes; Mice; Mice, Inbred BALB C; Mifepristone; Pregnancy; Pregnancy, Animal; Progesterone; Receptors, Progesterone; Spleen | 1990 |
[The importance of uterine vascular systems in the maintenance of pregnancy].
Topics: Abortion, Spontaneous; Animals; Culture Techniques; Female; Guinea Pigs; Mifepristone; Placenta; Pregnancy; Pregnancy, Animal; Uterus | 1989 |
[New data on the hormonal requirement of the pregnant rabbit: partial pregnancies and fetal abnormalities after treatment with a hormonal antagonist given at a sub-abortive dosage].
Topics: Abnormalities, Drug-Induced; Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Animals; Dose-Response Relationship, Drug; Estrenes; Female; Mifepristone; Pregnancy; Pregnancy, Animal; Progesterone; Rabbits | 1986 |
Fertility control in women: results with RU 486 by the end of 1985.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Spontaneous; Amenorrhea; Contraceptives, Postcoital; Estrenes; Female; Humans; Mifepristone; Models, Biological; Pregnancy | 1986 |